Clinical trial registry record

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated April 12, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT02054741
Last registry update
April 12, 2024
Status
Completed
Phase
Phase not reported
Sponsor
Supriya Mohile
Enrollment
733
Countries
United States
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · SUPPORTIVE CARE · NONE
Evidence population
Human clinical study registration
Participants
733
Population
ALL · 70 Years
Duration
2014-07-29 to 2021-10-31
Intervention
Comprehensive Geriatric Assessment; Quality-of-Life Assessment; Survey Administration
Comparator
Arm II (usual care)
Outcomes measured
Patient Experienced Any Grade 3-5 Toxicity — 3 months; Patient Survival at 6 Months — 6 months; Reduced Dose Intensity — 4-6 weeks; GA-driven Recommendations Made Among Patients With Impaired Physical Performance. — Baseline; GA-driven Recommendations Made Among Patients With Impaired Functional Status. — Baseline; GA-driven Recommendations Made Among Patients With Impaired Comorbidities. — Baseline; GA-driven Recommendations Made Among Patients With Impaired Cognition. — Baseline; GA-driven Recommendations Made Among Patients With Impaired Nutrition. — Baseline; GA-driven Recommendations Made Among Patients With Impaired Social Support. — Baseline; GA-driven Recommendations Made Among Patients With Impaired Polypharmacy. — Baseline; GA-driven Recommendations Made Among Patients With Impaired Psychological Status. — Baseline
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cancer and ageing · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

cancer and aging
Read the original source →Export JSON